DOI QR코드

DOI QR Code

Determinants of Cervical Cancer Screening Uptake in Kurdish Women Living in Western Iran, 2014

  • Aminisani, N (Epidemiology and Statistics Department, Faculty of Health Sciences, Tabriz University of Medical Siences) ;
  • Fattahpour, R (Epidemiology and Statistics Department, Faculty of Health Sciences, Tabriz University of Medical Siences) ;
  • Abedi, L (Kerman University of Medical Siences) ;
  • Shamshirgaran, SM (Epidemiology and Statistics Department, Faculty of Health Sciences, Tabriz University of Medical Siences)
  • Published : 2016.08.01

Abstract

Background: Cervical cancer is the second most common cancer among females across the world. It is a preventable cancer and early detection is very feasible. This study aimed to identify which women characteristics are potentially associated with and may have an important in uence on the uptake of cervical cancer screening in Kurdish women living in the west of Iran.. Materials and Methods: A cross sectional study was conducted in late 2014. A random sample of women aged 40 years and above without history of cervical cancer and identi ed as Kurdish background were selected and interviewed by two trained interviewers. Information about sociodemographic and reproductive factors, history of diseases, and cervical screening was collected using a questionnaire and women who had undergone a hysterectomy were excluded. Univariate analyses were used to describe the general characteristics of the study population. Multivariable logistic regression models with self-reported screening history were used to estimate odds ratios (ORs) with 95% con dence intervals (CI). Signi cance was considered at the 5% level. Results: A total of 561 women were included in this study (mean age $43.6{\pm}5.17$ years) participation in cervical screening at least once was about 32%. Cervical screening uptake percentage was signi cantly lower among people over 60 years of age (adjusted OR= 0.26, 95% CI: 0.11-0.64), and those who were illiterate (OR= 0.41 95% CI: 0.23-0.73) and post-menopausal (OR= 0.56, 95% CI: 0.35-0.91). Women with ${\leq}1$ child were less likely to report a Pap test (adjusted OR=0.43 95%CI: 0.13-1.37) Cervical screening uptake was higher among women with health insurance (OR= 2.31, 95% CI: 1.50-3.56). Conclusions: Cervical screening participation in this study was low compared to other studies in developed countries. The screening uptake was different based on age, education, parity, insurance coverage and menopausal status. It is recommended to target these groups of women in cervical screening program.

Keywords

Cervical cancer screening;socioeconomic status;minority;pap smear;Kurdish;Iran

References

  1. Akbari H, Jaddi Arani TS, Gilasi HR, et al (2013). Study of motivational factors and causes of nonparticipation to breast and cervical cancer screening tests among women attending health centers in Kashan city. Ilam Uni Med Sci J, 20, 137-47.
  2. Akinyemiju TF (2012). Socio-economic and health access determinants of breast and cervical cancer screening in low-income countries: analysis of the World Health Survey. PLoS One, 7, 48834. https://doi.org/10.1371/journal.pone.0048834
  3. Al-nsour M, Brown D, Tarawneh M, et al (2012). Breast and cervical cancer screening among women in Jordan. Open Breast Cancer J, 4, 1-7. https://doi.org/10.2174/1876817201204010001
  4. Aminisani N, Armstrong BK, Canfell K (2012a). Cervical cancer screening in Middle Eastern and Asian migrants to Australia: a record linkage study. Cancer Epidemiol, 36, e394-400. https://doi.org/10.1016/j.canep.2012.08.009
  5. Aminisani N, Armstrong BK, Canfell K (2012b). Participation in cervical screening by older asian and middle eastern migrants in new South wales, australia. Health Promot Perspect, 2, 274-86.
  6. Aminisani N, Armstrong BK, Egger S, et al (2012c). Impact of organised cervical screening on cervical cancer incidence and mortality in migrant women in Australia. BMC Cancer, 12, 491. https://doi.org/10.1186/1471-2407-12-491
  7. Downs LS, Smith JS, Scarinci I, et al (2008). The disparity of cervical cancer in diverse populations. Gynecol Oncol, 109, 22-30. https://doi.org/10.1016/j.ygyno.2008.01.003
  8. Enjezab B, Mojahed S, Bokaee M (2004). Barriers and motivators related to cervical and breast cancer screening. SSU Journals, 12, 78-84.
  9. Esmaeili M, Bonyadi M, Dastranj A, et al (2008). HPV typing in women with cervical precancerous and cancerous lesions in northwestern Iran. Gynecol Obstet Invest, 66, 68-72. https://doi.org/10.1159/000134917
  10. Ferlay J, Soerjomataram I, Dikshit R, et al (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136, 359-86. https://doi.org/10.1002/ijc.29210
  11. Ghahramani-Nasab P, Shahnazi M, Farshbaf Khalili A, et al (2013). Factors assiciated with cervical cancer screening among women refering to the Tabriz health centres, 2012- 2013. IJOGI, 16, 15-24.
  12. Jalilian F, Emdadi S (2011). Factors related to regular undergoing Pap-smear test: application of theory of planned behavior. J Res Health Sci, 11, 103-8.
  13. Kahesa C, Kjaer S, Mwaiselage J, et al (2012). Determinants of acceptance of cervical cancer screening in Dar es Salaam, Tanzania. BMC Public Health, 12, 1093. https://doi.org/10.1186/1471-2458-12-1093
  14. Khodakarami N, Clifford GM, Yavari P, et al (2012). Human papillomavirus infection in women with and without cervical cancer in Tehran, Iran. Int J Cancer, 131, 156-61. https://doi.org/10.1002/ijc.26488
  15. Khorasanizadeh F, Hassanloo J, Khaksar N, et al (2013). Epidemiology of cervical cancer and human papilloma virus infection among Iranian women - analyses of national data and systematic review of the literature. Gynecol Oncol, 128, 277-81. https://doi.org/10.1016/j.ygyno.2012.11.032
  16. Kitchener HC, Castle PE, Cox JT (2006). Chapter 7: Achievements and limitations of cervical cytology screening. Vaccine, 24, S3/63-70.
  17. Mandelblatt J, Traxler M, Lakin P, et al (1993). Targeting breast and cervical cancer screening to elderly poor black women: who will participate? The Harlem Study Team. Prev Med, 22, 20-33. https://doi.org/10.1006/pmed.1993.1002
  18. Mandelblatt JS, Phillips RN (1996). Cervical cancer: how often- -and why--to screen older women. Geriatrics, 51, 45-9.
  19. Meissner HI, Tiro JA, Haggstrom D, et al (2008). Does patient health and hysterectomy status influence cervical cancer screening in older women? J General Int Med, 23, 1822-8. https://doi.org/10.1007/s11606-008-0775-x
  20. Michalas SP (2000). The Pap test: George N. Papanicolaou (1883-1962). A screening test for the prevention of cancer of uterine cervix. Eur J Obstet Gynecol Reprod Biol, 90, 135-8. https://doi.org/10.1016/S0301-2115(00)00260-8
  21. Palencia L, Espelt A, Rodriguez-Sanz M, et al (2010). Socioeconomic inequalities in breast and cervical cancer screening practices in Europe: influence of the type of screening program. Int J Epidemiol, 39, 757-65. https://doi.org/10.1093/ije/dyq003
  22. Peirson L, Fitzpatrick-Lewis D, Ciliska D, et al (2013). Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev, 2, 35. https://doi.org/10.1186/2046-4053-2-35
  23. Soltan Ahmadi J, Abaszadeh A (2010). A survey on the rate and causes of women's participation or nonparticipation in breast and cervical cancers screening programs. IR J Obstet Gynecol Infertil, 13, 37-46.
  24. Zareai M (2014). Women's knowledge and practice about Pap smear test and it's barriers in Jahrom city. Pars Uni Med Sci J, 12.